A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis
Kim A. Reiss(University of Pennsylvania), Nilofer S. Azad(Johns Hopkins Hospital), Emily Petito(Sidney Kimmel Comprehensive Cancer Center), Naomi Horiba(University of Maryland, Baltimore), Laura A. Dawson(Princess Margaret Cancer Centre), Alice P. Chen(National Institutes of Health), Sarah M. Temkin(Anne Arundel Medical Center), Amy Hacker‐Prietz(Sidney Kimmel Comprehensive Cancer Center), Lillian L. Siu(University Health Network), Marianna Zahurak(Bloomberg (United States)), Caitlin Joffe(Sidney Kimmel Comprehensive Cancer Center), Anthony Brade(Princess Margaret Cancer Centre), Joseph M. Herman(Northwell Health), Robert J. Kinders(National Cancer Institute), Angela Scardina(Sidney Kimmel Comprehensive Cancer Center), Lihua Wang(National Cancer Institute)
Cited by 75
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k